Wall Street Analysts Think DexCom (DXCM) Could Surge 36.81%: Read This Before Placing a BetZacks Investment Research • 11/02/23
Weight-Loss Drugs Spooked Medical Device Stocks. Did Investors Overreact?Investors Business Daily • 10/27/23
Diabetes stocks jump as obesity-drug recovery comes ahead of schedule, analysts sayMarket Watch • 10/27/23
Dexcom Shrugs Off Pressure From Weight-Loss Drugs, Boosts 2023 Outlook. Stock Pops 14%.Investors Business Daily • 10/26/23
Glucose monitor maker DexCom's stock soars after big earnings beat, raised revenue outlook as real-time monitoring awareness growsMarket Watch • 10/26/23
Dexcom Reports Third Quarter 2023 Financial Results, Raises 2023 Revenue and Margin Guidance, and Announces $500 Million Share Repurchase ProgramBusiness Wire • 10/26/23
The weight-loss drugs are coming for these companies — but here's why Coke, others, may be spared, says JPMorganMarket Watch • 10/24/23
3 Stock-Split Stocks With 110% to 696% Upside, According to Select Wall Street Analysts and PunditsThe Motley Fool • 10/18/23